Lactobacillus and bifidobacteria combinations: A strategy to reduce hospital-acquired Clostridium difficile diarrhea incidence and mortality
- 31 August 2009
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 73 (2), 194-198
- https://doi.org/10.1016/j.mehy.2009.02.026
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiotaMicrobiology and Immunology, 2008
- Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric DiseaseAnnals of Internal Medicine, 2006
- Clostridium difficile-associated disease: new challenges from an established pathogen.Cleveland Clinic Journal of Medicine, 2006
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeThe Lancet, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Outbreak ofClostridium difficileInfection in a Long‐Term Care Facility: Association with Gatifloxacin UseClinical Infectious Diseases, 2004
- Prevention of antibiotic‐associated diarrhea in children by Clostridium butyricum MIYAIRIPediatrics International, 2003
- Treatment and prevention of antibiotic associated diarrheaInternational Journal of Antimicrobial Agents, 2000